Evidence map›Paper›PMID 39604638›Full record

ReviewArchives of pharmacal research2024

Exploring NNMT: from metabolic pathways to therapeutic targets.

Jeongwoo Park, Eun Jin Shin, Tae Hyun Kim, Ji Hye Yang, Sung Hwan Ki, Keon Wook Kang, Kyu Min Kim

Abstract readReview
PubMed Publisher
In one paragraph

Review in Archives of pharmacal research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jeongwoo ParkCollege of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 08826, Republic of Korea.
Eun Jin ShinDepartment of Biomedical Science, College of Natural Science, Chosun University, Gwangju, 61452, Republic of Korea.
Tae Hyun KimDrug Information Research Institute, Muscle Physiome Research Center, College of Pharmacy, Sookmyung Women's University, Seoul, 04310, South Korea.
Ji Hye YangCollege of Korean Medicine, Dongshin University, Naju, Jeollanam-Do, 58245, Republic of Korea.
Sung Hwan KiCollege of Pharmacy, Chosun University, Gwangju, 61452, Republic of Korea.
Keon Wook KangCollege of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 08826, Republic of Korea.
Kyu Min KimDepartment of Biomedical Science, College of Natural Science, Chosun University, Gwangju, 61452, Republic of Korea. kmkim@chosun.ac.kr.

Funding

National Research Foundation of Korea (NRF) 2018R1D1A1B07040460National Research Foundation of Korea (NRF) NRF-2021R1I1A305106914National Research Foundation of Korea (NRF) NRF-2022M3A9B6017654National Research Foundation of Korea (NRF) RS-2023-00285353
6 · The paper itself

Abstract

Cellular metabolism-related epigenetic modulation plays a pivotal role in the maintenance of cellular homeostasis. Nicotinamide N-methyltransferase (NNMT) serves as a crucial link between cellular metabolism and epigenetics by catalyzing nicotinamide methylation using the universal methyl donor S-adenosyl-L-methionine. This direct connection bridges the methylation-mediated one-carbon metabolism with nicotinamide adenine dinucleotide levels. Numerous studies have revealed tissue-specific differences in NNMT expression and activity, indicating that its varied physiological and pathological roles depend on its distribution. In this review, we provide an overview of the NNMT involvement in various pathological conditions, including cancer, liver disease, obesity, diabetes, brain disease, pulmonary disease, cardiovascular disease, and kidney disease. By synthesizing this information, our article aims to enhance our understanding of the cellular mechanisms underlying NNMT biology related to diverse diseases and lay the molecular groundwork for developing therapeutic strategies for pharmacological interventions.

Indexed as

Nicotinamide N-MethyltransferaseAnimalsEpigenesis, GeneticHumansMetabolic Networks and PathwaysMolecular Targeted TherapyNeoplasmsNicotinamide N-MethyltransferaseNNMT protein, humanDrug developmentMethylationNAD+Nicotinamide N-methyltransferase

Identifiers

PMID39604638

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.